Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32133407.
- Also identified by DOI 10.1126/sciadv.aay9269 and PMC identifier 7043914.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria parasites suppress host immune responses to facilitate their survival, but the underlying mechanism remains elusive. Here, we found that blood-stage malaria parasites predominantly induced CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> regulatory T cells to release soluble fibrinogen-like protein 2 (sFGL2), which substantially enhanced the infection. This was attributed to the capacity of sFGL2 to inhibit macrophages from releasing monocyte chemoattractant protein-1 (MCP-1) and to sequentially reduce the recruitment of natural killer/natural killer T cells to the spleen and the production of interferon-γ. sFGL2 inhibited c-Jun N-terminal kinase phosphorylation in the Toll-like receptor 2 signaling pathway of macrophages dependent on FcγRIIB receptor to release MCP-1. Notably, sFGL2 were markedly elevated in the sera of patients with malaria, and recombinant FGL2 substantially suppressed <i>Plasmodium falciparum</i> from inducing macrophages to release MCP-1. Therefore, we highlight a previously unrecognized immune suppression strategy of malaria parasites and uncover the fundamental mechanism of sFGL2 to suppress host innate immune responses.
Medical subject headings
- Fibrinogen
- Immunity, Innate
- Macrophages
- Malaria, Falciparum
- Plasmodium falciparum